UNION CITY, Calif., Nov. 12, 2010 /PRNewswire via COMTEX/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the release of ...
Lab-accurate blood chemistry analysis in real time will now be available in Canada thanks to Abaxis, Inc. (ABAX) which won Class III approval from Health Canada for its Piccolo Xpress and Piccolo ...
UNION CITY, Calif., Nov. 12, 2010 Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the release of a new Piccolo® reagent disc ...
Co announces that the FDA has granted waived status under CLIA regulations for four additional analytes, Calcium, Creatinine, Urea Nitrogen, and Uric Acid, when used in conjunction with the Piccolo ...
UNION CITY, Calif. Those retail-based clinics that shy away from treating conditions that require lab tests may now have a solution as Abaxis, a medical products company manufacturing point-of-care ...
UNION CITY, Calif. The Food and Drug Administration has given blood-analysis system manufacturer Abaxis a waived status for two analytes, creatine kinase and phosphorus, when used by healthcare ...
Lab-accurate blood chemistry analysis in real time will now be available in Canada thanks to Abaxis, Inc. ( ABAX) which won Class III approval from Health Canada for its Piccolo Xpress and Piccolo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results